ð¬ Current Disease Focus:
Task Progress: 0%
ð¥ Active Problem Solvers
0
ð Experts collaborating globally
â¡ Current Task Assignment
𧬠Genetic Analysis
ð Matching experts to specific tasks
ð Resource Allocation by Research Phase:
ð Data Analysis
𧪠Experimental Design
ð¬ Clinical Trials
ð Treatment Development
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the safety, reactog...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-19
Trial ID
NCT00756067
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-30
Trial ID
NCT00707798
Treatments Being Tested
This Phase 1 and Phase 2 study will evaluate the safety, tolerability and i...
Status
Completed
Location
Simon Williamson Clinic ( Site 0004)
Start Date
2019-12-06
Trial ID
NCT04168190
Treatments Being Tested
The purpose of this study is to determine whether Zoster Vaccine Live and P...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00535730
The purpose of this study is 1) to evaluate the safety and tolerability of ...
Status
Completed
Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Start Date
2019-06-25
Trial ID
NCT03885934
Treatments Being Tested
As the licensed pneumococcal vaccine is not always satisfactory in elderly,...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05-01
Trial ID
NCT00327665
The purpose of this study is to evaluate the safety and immunogenicity of s...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-28
Trial ID
NCT02225587
Treatments Being Tested
The purpose of this trial is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01153893
Treatments Being Tested
To describe the safety, tolerability and immunogenicity of pneumovax 23 (V1...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00496093
Treatments Being Tested